FHRX First Horizon Pharmaceutical (MM)

First Horizon Pharmaceutical Corporation (NASDAQ:FHRX), a specialty pharmaceutical company, will release financial results for the third quarter and nine months ended September 30, 2005, after the market closes on Wednesday, October 26, 2005. Conference Call First Horizon will also host a conference call on Wednesday, October 26, 2005, beginning at 5:00 p.m. Eastern time to discuss the financial results. Analysts, investors and other interested parties are invited to participate by visiting the Company's website, http://www.fhrx.com, and entering the Investor Relations page. You may also dial in to the conference call. The dial-in numbers are (800) 573-4840 for domestic callers and (617) 224-4326 for international callers. All callers should use passcode 64151068 to gain access to the conference call. Please plan to dial-in or log on at least ten minutes prior to the designated start time so management can begin promptly. Replay A seven-day telephonic replay of this conference call will be available by dialing (888) 286-8010 for domestic callers and (617) 801-6888 for international callers. Callers should use the passcode 59034363 to gain access to the replay, which will be available through the end of the day on November 2, 2005. The replay will be available on the Investor Relations page of the Company's website for seven days. First Horizon Background First Horizon Pharmaceutical Corporation is a specialty pharmaceutical company that markets, sells and develops prescription products with a primary focus on cardiology and women's health. First Horizon has a portfolio that includes 15 branded prescription products of which eight are actively promoted to high-prescribing physicians through its nationwide sales force of approximately 470 representatives. First Horizon's web site address is: www.fhrx.com. Please visit First Horizon's website for full prescribing information on First Horizon's products.